Valerie Ugo

Valerie Ugo

UNVERIFIED PROFILE

Are you Valerie Ugo?   Register this Author

Register author
Valerie Ugo

Valerie Ugo

Publications by authors named "Valerie Ugo"

Are you Valerie Ugo?   Register this Author

53Publications

1379Reads

18Profile Views

WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.

Blood Cells Mol Dis 2019 03 20;75:35-40. Epub 2018 Dec 20.

Université Angers, UFR Santé, Angers, France; CHU Angers, Laboratoire d'Hématologie, Angers, France; INSERM, CRCINA, Université de Nantes, Université d'Angers, France; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2018.12.004DOI Listing
March 2019

Concomitant CALR and LNK mutations leading to essential thrombocythemia with erythrocytosis.

Blood Cells Mol Dis 2018 07 23;71:75-76. Epub 2018 Apr 23.

CHU Angers, Laboratoire d'Hématologie, Institut de Biologie en Santé, Angers, France; Université d'Angers, UFR Santé, Angers, France; CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France; Fédération Hospitalo-Universitaire (FHU) GOAL, 'Grand Ouest Against Leukemia', France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2018.04.002DOI Listing
July 2018

Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor.

Platelets 2018 May 26;29(3):257-264. Epub 2018 Mar 26.

a Service d'hématologie Biologique, CHRU de Brest , Brest , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09537104.2018.1453058DOI Listing
May 2018

Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.

Hematol Oncol 2017 Sep 2;35(3):385-389. Epub 2015 Nov 2.

Faculté de Médecine et des Sciences de la Santé, Université de Brest, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2268DOI Listing
September 2017

JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort.

Ann Hematol 2017 Mar 20;96(3):383-386. Epub 2016 Oct 20.

Institut National de la Santé et de la Recherche Médicale (INSERM), EA-3878 G.E.T.B.O. (Groupe d'Etude de la Thrombose en Bretagne Occidentale), Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2853-1DOI Listing
March 2017

A new point mutation in EPOR inducing a short deletion in congenital erythrocytosis.

Br J Haematol 2016 Feb 26;172(3):475-7. Epub 2015 May 26.

CHU Brest, Laboratoire d'Hématologie, Brest, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13511
Publisher Site
http://dx.doi.org/10.1111/bjh.13511DOI Listing
February 2016

Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 (V617F) and JAK2 exon 12 allele burden disappearance during the follow-up of two patients.

Ann Hematol 2016 Feb 27;95(3):529-31. Epub 2015 Nov 27.

Service d'Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Hôpital Morvan, Avenue Foch, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2559-9DOI Listing
February 2016

Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism.

Thromb Haemost 2016 Jan 20;115(1):225-6. Epub 2015 Aug 20.

Jean-Christophe Ianotto, Service d'Hématologie Clinique, Institut de Cancéro-Hématologie, Hôpital Morvan - CHRU Brest, 29609 Brest Cedex, France, Tel.: +33 298223504, Fax: +33 298223223, E-mail

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-02-0134DOI Listing
January 2016

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.

Blood 2016 Jan 8;127(3):333-42. Epub 2015 Oct 8.

INSERM, Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France; Université Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France; UMR1170, Gustave Roussy, Villejuif, France; Consultation d'Hématologie-Immunologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-661983DOI Listing
January 2016

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Ann Hematol 2016 Jan 13;95(2):349-50. Epub 2015 Oct 13.

CHU Angers, Laboratoire d'Hématologie, 4 Rue Larrey, 49933, Angers Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2518-5DOI Listing
January 2016

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.

Blood 2015 Dec 20;126(24):2585-91. Epub 2015 Oct 20.

Université Paris Diderot, Paris, France; and Centre d'Investigations Cliniques, Hopital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-659060DOI Listing
December 2015

MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.

Leuk Res 2014 Nov 29;38(11):1316-9. Epub 2014 Aug 29.

Laboratoire d'Histologie, Embryologie et Cytogénétique, Faculté de Médecine et des Sciences de la Santé, Université de Brest, Brest, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, France; Service de Cytogénétique et Biologie de la Reproduction, Hôpital Morvan, CHRU Brest, Brest, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.08.011DOI Listing
November 2014

Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.

Thromb Res 2010 Sep 24;126(3):238-42. Epub 2010 Jul 24.

CHU Brest, Laboratoire d'Hématologie, Hôpital La Cavale Blanche, INSERM, U613, Université de Brest, UFR Médecine et Sciences de la Santé, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2010.06.025DOI Listing
September 2010

[Polycytaemia vera].

Authors:
Valérie Ugo

Rev Prat 2009 Nov;59(9):1285-6

Laboratoire d'hématologie, CHU Brest, 29200 Brest, France.

View Article

Download full-text PDF

Source
November 2009

Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.

Ann Hematol 2008 Jul 19;87(7):537-44. Epub 2008 Mar 19.

Laboratoire d'Histologie, Embryologie et Cytogénétique, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-008-0462-3DOI Listing
July 2008

Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.

Leuk Res 2008 May 5;32(5):743-54. Epub 2007 Nov 5.

Laboratoire de Thérapie Cellulaire et d'Immuno-Biologie du Cancer, EA 2216-CHU de Brest-Hôpital Morvan, 29609 Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.09.011DOI Listing
May 2008

[Polycythemia vera].

Authors:
Valérie Ugo

Rev Prat 2006 Nov;56(17):1941-7; quiz 1948

Laboratoire d'hématologie, Centre hospitalier universitaire de Brest, 29200 Brest.

View Article

Download full-text PDF

Source
November 2006

Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.

Blood 2006 Sep 9;108(5):1551-4. Epub 2006 May 9.

Unité (U) 790 Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-10-009514DOI Listing
September 2006

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.

Trends Mol Med 2005 Dec 3;11(12):546-54. Epub 2005 Nov 3.

INSERM U362, Institut Gustave Roussy, Paris XI University, PR1, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2005.10.003DOI Listing
December 2005

[A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera].

Med Sci (Paris) 2005 Jun-Jul;21(6-7):669-70

Inserm U.362, PR1, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2005216-7669DOI Listing
September 2005

[The place of growth factors in the treatment of myelodysplastic syndromes].

Pathol Biol (Paris) 2002 May;50(4):268-74

Service d'Hématologie Biologique, Hôtel Dieu, 1, place du parvis de Notre Dame, 75004 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0369-8114(02)00301-2DOI Listing
May 2002

[New WHO classification of myelodysplastic syndromes. The consequences].

Authors:
Valérie Ugo

Pathol Biol (Paris) 2002 May;50(4):278-82

Service d'Hématologie Biologique, Hôtel Dieu, 1, place du parvis de Notre-Dame, 75004 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0369-8114(02)00300-0DOI Listing
May 2002

[Update on malignant hemopathies].

Bull Cancer 2002 Jan;89(1):75-88

Département d'hématologie et d'oncologie médicale, Hôtel-Dieu, 75181 Paris Cedex 04 et Inserm EMI9912/EA1529, Paris 6.

View Article

Download full-text PDF

Source
January 2002